Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Metastasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Study completedNCT01941407
What this trial is testing

First Line Metastatic Breast Cancer Treatment (ESMERALDA)

Who this might be right for
Metastatic Breast Cancer
ARCAGY/ GINECO GROUP 61
Testing effectiveness (Phase 2)Study completedNCT03890731
What this trial is testing

A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed

Who this might be right for
Solid Cancer
Bayer 6
Testing effectiveness (Phase 2)Study completedNCT03193853
What this trial is testing

TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Joyce O'Shaughnessy 12
Not applicableUnknownNCT03983577
What this trial is testing

Efficacy of Point Of Service Testing in MBC

Who this might be right for
Metastatic CancerBreast Cancer
University of Kansas Medical Center 100
Not applicableStudy completedNCT07778407
What this trial is testing

TDXD in Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Advanced Malignancies
Mansoura University 25
Early research (Phase 1)Study completedNCT02812667
What this trial is testing

Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer Metastatic
Lyudmila Bazhenova, M.D. 18
Testing effectiveness (Phase 2)Ended earlyNCT01508000
What this trial is testing

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

Who this might be right for
Colorectal Cancer MetastaticLiver MetastasesKRAS Wild Type Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Large-scale testing (Phase 3)Study completedNCT02028507
What this trial is testing

Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors

Who this might be right for
Metastatic Breast Cancer
Spanish Breast Cancer Research Group 693
Post-approval studies (Phase 4)Study completedNCT02567331
What this trial is testing

Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 28
Testing effectiveness (Phase 2)Study completedNCT02259231
What this trial is testing

RTA 408 Capsules in Patients With Melanoma - REVEAL

Who this might be right for
MelanomaUnresectable (Stage III) MelanomaMetastatic (Stage IV) Melanoma
Biogen 41
Early research (Phase 1)Looking for participantsNCT07563829
What this trial is testing

NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT06402331
What this trial is testing

FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Fusion Pharmaceuticals Inc. 110
Testing effectiveness (Phase 2)Looking for participantsNCT05010031
What this trial is testing

Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

Who this might be right for
Metastatic Cancer
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)UnknownNCT00287131
What this trial is testing

Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients

Who this might be right for
Metastatic Melanoma
Sheba Medical Center 70
Testing effectiveness (Phase 2)UnknownNCT02544737
What this trial is testing

Apatinib for Metastatic Esophageal Cancer.

Who this might be right for
Esophageal CancerMetastatic Esophageal CancerApatinib
Hangzhou Cancer Hospital 29
Testing effectiveness (Phase 2)Study completedNCT00353145
What this trial is testing

Gemox as First and Second Line Therapy in Unknown Primary Cancer

Who this might be right for
Unknown Primary Neoplasms
M.D. Anderson Cancer Center 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT07025239
What this trial is testing

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 430
Early research (Phase 1)Study completedNCT04252339
What this trial is testing

RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor, Unspecified, Adult
Hoffmann-La Roche 56
Not applicableStudy completedNCT02963675
What this trial is testing

Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in Sweden

Who this might be right for
Prostatic Neoplasms
Bayer 15,953
Next Page